Skip to main content

argenx to Report Third Quarter 2026 Financial Results and Business Update on October 22, 2026

October 15, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology innovation company, today announced that it will host a conference call and audio webcast on Thursday, October 22, 2026 at 2:30 PM CET (8:30 AM ET) to discuss its third quarter 2026 financial results and provide a business update. A webcast of the live call may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately one year following the presentation. Participants can access the conference call by dialing 800-590-8290 (United States and Canada) or 240-690-8800 (International). Country specific dial-in numbers are listed below: Belgium                32 2290 4635France                        33 172 001717Netherlands                31...

Continue reading

IBA selected to support the US expansion of a leading radiopharmaceutical producer with an order for 12 Cyclone® KIUBE systems

IBA is preferred supplier for a 12-system national PET radiopharmaceutical production network, securing capacity ahead of demand across diagnostics and theranostics Louvain-la-Neuve, Belgium – October 15, 2026, 7 a.m. – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of radiopharmaceutical production solutions, today announced that a leading global producer and distributor of radiopharmaceuticals has selected IBA as preferred vendor for the expansion of its production network in the United States with an order of 12 Cyclone® KIUBE 300 solutions to secure the production of radioisotopes for diagnostic and therapeutic applications. Industrial capacity has become the gating factor in radiopharmaceuticals today. Clinical pipelines are broadening across both diagnostics...

Continue reading

Kuros Biosciences increases 2026 annual guidance, The company reports 40% year-over-year increase in sales in the first nine months of 2026

Ad hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences increases 2026 annual guidanceThe company reports 40% year-over-year increase in sales in the first nine months of 2026 Schlieren (Zurich), Switzerland, October 15, 2026 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, today announced its financial performance for the first nine months of 2026. Financial HighlightsTotal Medical Device sales increased 40% to USD 141.8 million (9M 2025: USD 101.1 million) Total Group EBITDA increased 81% to USD 13.5 million (9M 2025: USD 7.4 million) The Group adjusted EBITDA* increased 68% to USD 20.6 million, equaling a margin of 14.5% (9M 2025: USD 12.2 million or 12.1%) Cash position ahead of plan at USD 19.6 million, up from USD 9.7 million as of June 30, 2026Operational...

Continue reading

AIR Announces Capital Return Framework

Establishes Quarterly Dividend Policy and Share Repurchase Program Supported by Strong Cash Flow Generation DUBAI, United Arab Emirates, Oct. 15, 2026 (GLOBE NEWSWIRE) — AIR (Nasdaq: AIIR) today announced the establishment of a formal capital return framework designed to enhance shareholder returns while maintaining investment capacity for growth and preserving a disciplined balance sheet. Under the framework, the Company intends to return capital to shareholders through a combination of regular cash dividends and share repurchases, supported by the Company’s strong and growing equity free cash flow generation. Quarterly Dividend Policy AIR intends to initiate an annual cash dividend policy. For the 2027 fiscal year, the Company’s Board of Directors has approved a cash dividend of US$0.28 per share, to be paid in quarterly...

Continue reading

Net asset value of the EfTEN United Property Fund unit increased by 0.5% to 11.65 euros in September

In September, EfTEN United Property Fund earned a net profit of 152 thousand euros, and 777 thousand euros over the first nine months of 2026 (2,105 thousand euros in the same period last year). The net asset value (NAV) of the fund unit was 11.65 euros at the end of September, increasing by 0.5% over the month. In September, all of the fund’s investments were profitable. The fund earned the largest profit (81,350 euros) from its investment in EfTEN Real Estate Fund 5. The financial results of the fund are driven by its investments in two retail centres – Kristiine shopping centre in Tallinn and UNA retail park in Vilnius. At the end of September, the occupancy of both centres was 100%. No new sales agreements were signed in September at Invego Uus-Järveküla OÜ, the development company in which the fund holds an 80% stake. Three terraced...

Continue reading

Sigenergy Opens a New Chapter in Sri Lanka with Smart Energy Solutions

COLOMBO, Sri Lanka, Oct. 15, 2026 (GLOBE NEWSWIRE) — Sigenergy has just officially launched its brand in Sri Lanka under the theme “Powering a New Era of Smart Energy in Sri Lanka,” marking an important milestone in the company’s regional expansion and commitment to advancing the country’s clean energy transition.The event brought together distinguished guests, industry leaders, business partners, and customers to explore the latest innovations in smart energy technology. Among the distinguished attendees was Mr. Rohana Rambodage, Director General of the Sri Lanka Sustainable Energy Authority, who delivered the opening remarks, highlighting the importance of sustainable energy development and industry collaboration in supporting the transition to a cleaner energy future. The program opened with Mr. Marvin Xiao, Regional Director...

Continue reading

Deep Drilling Intersects Epithermal Mineralisation 1 km Below Proprietary Pit at Peak Hill

PERTH, Australia, Oct. 14, 2026 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK, TSX: ALK, OTCQX: ALKRY) (‘Alkane’) is pleased to announce the latest exploration results at its Peak Hill Gold Project (Peak Hill) in New South Wales. SummaryAlkane was awarded an NSW Critical Minerals exploration grant of $165,000 to explore for a copper-gold porphyry at Peak Hill. One diamond core drill hole (PHD084), was completed to 1,651 m, intersecting transitional phyllic alteration beneath the Great Eastern open cut suggesting the targeted porphyry environment may be deeper. A study has been commissioned to evaluate the proximity of possible porphyry intrusives to PHD084 before further testing this target. Deeper down hole and approximately 1 km vertically below the Proprietary open cut, PHD084 intersected the same advanced argillic...

Continue reading

Interpace Biosciences Announces Preliminary Unaudited Third Quarter 2026 Revenue

Preliminary Q3 2026 revenue expected to range from $10.1 million to $10.4 million Expected quarter-over-quarter growth of approximately 11% to 14% compared with Q2 2026 Expected year-over-year growth of approximately 15% to 18% compared with Q3 2025PARSIPPANY, NJ, Oct. 14, 2026 (GLOBE NEWSWIRE) — Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCID: IDXG) today announced that it expects preliminary, unaudited revenue for the third quarter ended September 30, 2026 to range from $10.1 million to $10.4 million. The expected revenue range represents an increase of approximately 11% to 14% compared with revenue of $9.1 million for the second quarter of 2026 and an increase of approximately 15% to 18% compared with revenue of $8.8 million for the third quarter of 2025. The estimated revenue presented...

Continue reading

Coastal Community Bank Commits $5 Million to Support Small Business Growth and Economic Opportunity

Investment in SBA loan fund expands access to capital for local businesses and job creation EVERETT, Wash., Oct. 14, 2026 (GLOBE NEWSWIRE) — Coastal Community Bank (the “Bank”, “Coastal”, “us”, “our”, “we”) announced a $5 million investment in the Solomon Hess SBA Loan Fund, reinforcing the Bank’s commitment to supporting small businesses, economic development, and job creation throughout Snohomish and King Counties. The investment advances Coastal’s Federal Reserve-approved Community Reinvestment Act (CRA) Strategic Plan and expands access to capital for businesses that may not qualify for traditional financing. The investment supports the SBA 7(a) loan program, which helps small businesses secure financing needed to grow, create jobs, and contribute to local economic development. By purchasing federally guaranteed...

Continue reading

Brookfield Renewable Corporation Shareholders Approve Proposed Corporate Simplification

BROOKFIELD, NEWS, Oct. 14, 2026 (GLOBE NEWSWIRE) — Brookfield Renewable Partners L.P. (“BEP”) (NYSE: BEP; TSX: BEP.UN) and Brookfield Renewable Corporation (“BEPC”) (TSX, NYSE: BEPC) today announced that BEPC shareholders voted in favour of the resolution approving the proposed corporate structure simplification (the “Simplification”) at a special meeting held virtually earlier today (the “Shareholders’ Meeting”). Brookfield Renewable also reminds BEP unitholders that the special meeting of unitholders of BEP (the “Unitholders’ Meeting”) will be held on October 29, 2026 at 11:00 a.m. EDT. Reminder to BEP Unitholders to Vote BEP unitholders who have not yet voted are encouraged to vote their units today. The Board of Directors of BEP, based in part on the unanimous recommendation of its nominating and governance committee (consisting...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.